Most cited papers from Karo Pharma (Sweden)
What are the most cited papers from Karo Pharma (Sweden)?
The most cited paper from Karo Pharma (Sweden) is "Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors α and β" (George G. J. M. Kuiper, Bo Carlsson, Kaj Grandien et al., 1997), with 4,457 citations. Next come "Molecular basis of agonism and antagonism in the oestrogen receptor" (3,370) and "Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites" (1,865).
Showing 50 of 60 papers. Every paper with more than 72 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors α and β George G. J. M. Kuiper, Bo Carlsson, Kaj Grandien et al. · Endocrinology | Mar 1997 | 4,457 |
| 2 | Molecular basis of agonism and antagonism in the oestrogen receptor Andrzej Marek Brzozowski, Ashley C. W. Pike, Zbigniew Dauter et al. · Nature | Oct 1997 | 3,370 |
| 3 | Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites Kolja Paech, Paul M. Webb, George G. J. M. Kuiper et al. · Science | 5 Sep 1997 | 1,865 |
| 4 | Structure of the ligand‐binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist Ashley C. W. Pike, Andrzej M. Brzozowski, Roderick E. Hubbard et al. · The EMBO Journal | Sep 1999 | 981 |
| 5 | Differential Response of Estrogen Receptor α and Estrogen Receptor β to Partial Estrogen Agonists/Antagonists Tomas Barkhem, Bo Carlsson, Yvonne Nilsson et al. · Molecular Pharmacology | Jul 1998 | 779 |
| 6 | Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression Yuichi Makino, Renhai Cao, Kristian Svensson et al. · Nature | Nov 2001 | 703 |
| 7 | An expert system model for mapping tropical wetlands and peatlands reveals South America as the largest contributor Thomas Gumbricht, Rosa María Román-Cuesta, Louis Vincent Verchot et al. · Global Change Biology | 15 Mar 2017 | 448 |
| 8 | A role for estrogen receptor β in the regulation of growth of the ventral prostate Zhang Weihua, Sari Mäkelä, Leif Christer Andersson et al. · Proceedings of the National Academy of Sciences | 22 May 2001 | 440 |
| 9 | The Estrogen Receptor Enhances AP-1 Activity by Two Distinct Mechanisms with Different Requirements for Receptor Transactivation Functions Paul M. Webb, Phuong Trang Nguyen, Cathleen D. Valentine et al. · Molecular Endocrinology | Oct 1999 | 387 |
| 10 | Evidence that oestrogen receptor-α plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver Galyna Bryzgalova, Hui Gao, Bo Åhrén et al. · Diabetologia | 3 Feb 2006 | 387 |
| 11 | Estrogen Receptors: Therapies Targeted to Receptor Subtypes S. Nilsson, J-Å Gustafsson · Clinical Pharmacology & Therapeutics | Dec 2010 | 370 |
| 12 | Estrogen receptors α and β in the rodent mammary gland Shigehira Saji, Elwood V. Jensen, Stefan V. Nilsson et al. · Proceedings of the National Academy of Sciences | 4 Jan 2000 | 360 |
| 13 | Reflections on the Discovery and Significance of Estrogen Receptor β Konrad F. Koehler, Luisa Alejandra Helguero, Lars-Arne Haldosén et al. · Endocrine Reviews | 27 Apr 2005 | 357 |
| 14 | Structural Insights into the Mode of Action of a Pure Antiestrogen Ashley C. W. Pike, Andrzej Marek Brzozowski, Julia Walton et al. · Structure | Feb 2001 | 350 |
| 15 | Amino acid sequence of PR‐39 Birgitta Agerberth, Jong‐Youn LEE, Tomas Bergman et al. · European Journal of Biochemistry | Dec 1991 | 347 |
| 16 | The Three-dimensional Structures of Antagonistic and Agonistic Forms of the Glucocorticoid Receptor Ligand-binding Domain Björn Kauppi, Clarissa G. Jakob, Mathias Färnegårdh et al. · Journal of Biological Chemistry | Jun 2003 | 342 |
| 17 | Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated Dyslipidemia Paul W. Ladenson, Jens D. Kristensen, E. Chester Ridgway et al. · New England Journal of Medicine | 10 Mar 2010 | 338 |
| 18 | Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders Marie K. Österlund, Yasmin L. Hurd · Progress in Neurobiology | Jun 2001 | 268 |
| 19 | Development of subtype-selective oestrogen receptor-based therapeutics Stefan V. Nilsson, Konrad F. Koehler, Jan-Åke Gustafsson · Nature Reviews Drug Discovery | 16 Sep 2011 | 250 |
| 20 | Biological Role of Estrogen and Estrogen Receptors Stefan V. Nilsson, Jan-Åke Gustafsson · Critical Reviews in Biochemistry and Molecular Biology | 2002 | 244 |
| 21 | Selective thyroid hormone receptor-β activation: A strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability Gary J. Grover, Karin Mellström, Ye Liu et al. · Proceedings of the National Academy of Sciences | 29 Jul 2003 | 224 |
| 22 | The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans Anders Berkenstam, Jens D. Kristensen, Karin Mellström et al. · Proceedings of the National Academy of Sciences | 26 Dec 2007 | 194 |
| 23 | Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease Juan Jesús Carrero, Abdul Rashid Qureshi, Jonas Axelsson et al. · Journal of Internal Medicine | 3 Oct 2007 | 188 |
| 24 | The Anabolic Effects of Human Parathyroid Hormone (hPTH) on Rat Vertebral Body Mass Are also Reflected in the Quality of Bone, Assessed by Biomechanical Testing: A Comparison Study between hPTH-(1–34) and hPTH-(1–84)* Li. Mosekilde, C.H. Søgaard, Carl Christian Danielsen et al. · Endocrinology | Jul 1991 | 180 |
| 25 | The anabolic effect of human PTH (1–34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate—is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system? Pierre Dominique Delmas, Philippe Vergnaud, MONIQUE E. ARLOT et al. · Bone | Jun 1995 | 172 |
| 26 | The Three-dimensional Structure of the Liver X Receptor β Reveals a Flexible Ligand-binding Pocket That Can Accommodate Fundamentally Different Ligands Mathias Färnegårdh, Tomas Bonn, Sherry Xiaoyun Sun et al. · Journal of Biological Chemistry | 26 Sep 2003 | 164 |
| 27 | The Orphan Nuclear Receptor SHP Utilizes Conserved LXXLL-Related Motifs for Interactions with Ligand-Activated Estrogen Receptors Lotta Johansson, Ann Båvner, Jane S. Thomsen et al. · Molecular and Cellular Biology | Feb 2000 | 160 |
| 28 | Human parathyroid hormone (1–34) and (1–84) increase the mechanical strength and thickness of cortical bone in rats Charlotte Ejersted, T. T. Andreassen, Hans Oxlund et al. · Journal of Bone and Mineral Research | Sep 1993 | 158 |
| 29 | Estrogen receptor transcription and transactivation Basic aspects of estrogen action Stefan V. Nilsson, Jan-Ακε Gustafsson · Breast Cancer Research | Oct 2000 | 155 |
| 30 | Thyroxine-Thyroid Hormone Receptor Interactions Ben Sandler, Paul M. Webb, James W. Apriletti et al. · Journal of Biological Chemistry | 4 Oct 2004 | 150 |
| 31 | Thyroid Receptor Ligands. 1. Agonist Ligands Selective for the Thyroid Receptor β1 Ye Liu, Yilin Li, Karin Mellström et al. · Journal of Medicinal Chemistry | 21 Mar 2003 | 143 |
| 32 | Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study Barbara Sjouke, Gisle Langslet, R Češka et al. · The Lancet Diabetes & Endocrinology | 17 Feb 2014 | 142 |
| 33 | Parathyroid Hormone (1–34) and (1–84) Stimulate Cortical Bone Formation Both from Periosteum and Endosteum Hans Oxlund, Charlotte Ejersted, T. T. Andreassen et al. · Calcified Tissue International | Dec 1993 | 137 |
| 34 | Expression of a novel member of estrogen response element-binding nuclear receptors is restricted to the early stages of chorion formation during mouse embryogenesis Katarina Pettersson, Kristian Svensson, Ragnar Mattsson et al. · Mechanisms of Development | Feb 1996 | 136 |
| 35 | The estrogen receptor family Margaret N. Warner, Stefan V. Nilsson, Jan-Ακε Gustafsson · Current Opinion in Obstetrics & Gynecology | Jun 1999 | 129 |
| 36 | Estren Is a Selective Estrogen Receptor Modulator with Transcriptional Activity Sofia Movérare, Johanna Dahllund, Niklas Andersson et al. · Molecular Pharmacology | 27 Nov 2003 | 126 |
| 37 | Synthesis and Preliminary Characterization of a Novel Antiarrhythmic Compound (KB130015) with an Improved Toxicity Profile Compared with Amiodarone Bo Carlsson, Bramah N. Singh, Marcel Temciuc et al. · Journal of Medicinal Chemistry | 2002 | 119 |
| 38 | Remote Dipole Effects as a Means to Accelerate [Ru(amino alcohol)]-Catalyzed Transfer Hydrogenation of Ketones Sofia J. M. Nordin, Peter R. Roth, Tibor Tarnai et al. · Chemistry - A European Journal | Apr 2001 | 108 |
| 39 | Thyroid hormone reduces PCSK9 and stimulates bile acid synthesis in humans Ylva Bonde, Olof Breuer, Dieter Lütjohann et al. · Journal of Lipid Research | 30 Aug 2014 | 103 |
| 40 | MOLECULAR AND STRUCTURAL BIOLOGY OF THYROID HORMONE RECEPTORS James W. Apriletti, Ralff C.J. Ribeiro, Richard Wagner et al. · Clinical and Experimental Pharmacology and Physiology | Nov 1998 | 103 |
| 41 | Estrogen Receptor Ligands. II. Discovery of Benzoxathiins as Potent, Selective Estrogen Receptor α Modulators Seongkon Kim, Jane Y. Wu, Elizabeth T. Birzin et al. · Journal of Medicinal Chemistry | 20 Mar 2004 | 103 |
| 42 | Molecular Mechanisms, Physiological Consequences and Pharmacological Implications of Estrogen Receptor Action Tomas Barkhem, Stefan V. Nilsson, Jan- ke Gustafsson · American Journal of PharmacoGenomics | 2004 | 101 |
| 43 | Physiology of cultured animal cells Magnus Doverskog, Jan Gustaf Ljunggren, Lars Öhman et al. · Journal of Biotechnology | Dec 1997 | 98 |
| 44 | High level expression of functional full length and truncated glucocorticoid receptor in Chinese hamster ovary cells. Demonstration of ligand-induced down-regulation of expressed receptor mRNA and protein M. Alksnis, T. Barkhem, P E Strömstedt et al. · Journal of Biological Chemistry | Jun 1991 | 98 |
| 45 | Estrogen Receptor Action Stefan V. Nilsson, Jan-Ακε Gustafsson · Critical Reviews in Eukaryotic Gene Expression | 2002 | 97 |
| 46 | Involvement of corepressor complex subunit GPS2 in transcriptional pathways governing human bile acid biosynthesis Sabyasachi Sanyal, Ann Båvner, Anna Haroniti et al. · Proceedings of the National Academy of Sciences | 25 Sep 2007 | 97 |
| 47 | Evidence for the Presence of Functional Thyrotropin Receptor in Cardiac Muscle Viktor Drvota, Annika Janson, Catalina Norman et al. · Biochemical and Biophysical Research Communications | Jun 1995 | 96 |
| 48 | Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor β subtype selective agonist KB-141 Galina Bryzgalova, Suad Effendic, Akhtar Khan et al. · The Journal of Steroid Biochemistry and Molecular Biology | 23 Jun 2008 | 94 |
| 49 | Underlying mechanisms mediating the antidepressant effects of estrogens Marie K. Österlund · Biochimica et Biophysica Acta (BBA) - General Subjects | 13 Nov 2009 | 93 |
| 50 | ERβ a Novel Estrogen Receptor Offers the Potential for New Drug Development Stefan V. Nilsson, George G. J. M. Kuiper, Jan-Ακε Gustafsson · Trends in Endocrinology and Metabolism | Dec 1998 | 84 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.